Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. - Banchereau,J.; Palucka,A.K.; Dhodapkar,M.; Burkeholder,S.; Taquet,N.; Rolland,A.; Taquet,S.; Coquery,S.; Wittkowski,K.M.; Bhardwaj,N.; Pineiro,L.; Steinman,R.; et al. (Cancer Res, 2001)